Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8E4B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,462
Award facts
- Contract value 100% obligated
- $20,462.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,462.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Beyfortus 50 mg/0.5 ml syringes (0.5 ml units). The contract, which is expected to be completed by January 8, 2026, was awarded without a set-aside designation through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This award represents a routine pharmaceutical supply transaction under the broader IDC vehicle that enables Cencora to furnish a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody used for passive immunization, reflecting the Defense Health Agency's continued need for specialized immunological products to protect military personnel and beneficiaries. The firm fixed-price structure and minimal completion timeline indicate this is a straightforward procurement fulfilling immediate medical supply requirements within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F8E4B?
SPE2DR26F8E4B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F8E4B worth?
The government has obligated $20,462 on SPE2DR26F8E4B.
Is contract SPE2DR26F8E4B an order under another contract?
Yes. SPE2DR26F8E4B is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E4B competed?
The extent of competition for SPE2DR26F8E4B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award